Abstract
The enzyme indoleamine 2,3-dioxygenase (IDO) contributes to immune tolerance in a variety of settings. In cancer IDO is expressed within the tumor itself as well as in antigen-presenting cells in tumor-draining lymph nodes, where it endorses the establishment of peripheral immune tolerance to tumor antigens. Recently, we described cytotoxic CD8(+) T-cell reactivity towards IDO-derived peptides.
| Original language | English |
|---|---|
| Journal | P L o S One |
| Volume | 7 |
| Issue number | 4 |
| Pages (from-to) | e34568 |
| ISSN | 1932-6203 |
| DOIs | |
| Publication status | Published - 2012 |
Keywords
- Aged
- Antineoplastic Agents
- CD8-Positive T-Lymphocytes
- Epitopes
- Female
- HLA-A2 Antigen
- Histocompatibility Antigens Class II
- Humans
- Indoleamine-Pyrrole 2,3,-Dioxygenase
- Interferon-gamma
- Interleukin-10
- Interleukin-17
- Male
- Melanoma
- Middle Aged
- Peptides
- T-Lymphocytes, Helper-Inducer
- Tumor Necrosis Factor-alpha
Fingerprint
Dive into the research topics of 'Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenase'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS